UPB compared with CMPX: revenue, margins and what each company keeps, and the suppliers and customers both name

UPBUpstream Bio, Inc.

Mkt capRevenueRevenue

CMPXCompass Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

UPBUpstream Bio, Inc.

CMPXCompass Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

UPB

1 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▼−4.70%—

May 13 '26±10.6%▲+4.58%×0.43

Q1 FY26±38.9%▲+3.38%×0.09

Feb 11 '26±32.0%▼−47.18%×1.48

CMPX

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▲+5.29%—

May 5 '26±16.1%▲+0.52%×0.03

= impliedUPB realized, solidCMPX realized, hatchedOne scale, both sides: full bar = 53%× = |realized| ÷ impliedSource: market data

Q1 FY26

±52.0%

▼−2.81%

×0.05

Jan 6 '26±33.6%▼−1.60%×0.05

UPBUpstream Bio, Inc.

3.38▲+0.90%· post 3.38

Mkt cap$185.0MRevenue$773,000Q2 FY26Revenue$3MFY25

CMPXCompass Therapeutics, Inc.

0.77▼−0.29%· post 0.76

ClosedNov 3 '26

Mkt cap$135.6MRevenue$850,000Q2 FY24Revenue—

Compare

ClosedNov 3 '26

UPBUpstream Bio, Inc.

CMPXCompass Therapeutics, Inc.

3.38▲+0.90%post 3.38

Price

0.77▼−0.29%post 0.76

$185.0M

Mkt cap

$135.6M

Q2 FY26$773,000

Revenue

$850,000Q2 FY24

FY25$3M

Revenue

—

UPB3.38▲+0.90%vsCMPX0.77▼−0.29%ClosedNov 3 '26